Editor's Note This new study from the Cleveland Clinic found that use of COVID-19 antiviral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduces risk of hospitalization and death in high-risk patients with mild disease, even against Omicron subvariants. The findings were published in JAMA Network on September 21. The study included…